iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
-0.080 (-6.25%)
At close: Dec 5, 2025, 4:00 PM EST
1.200
0.00 (0.02%)
After-hours: Dec 5, 2025, 7:52 PM EST
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$25,000
Profits / Employee
-$1,005,400
Market Cap
26.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IBIO News
- 11 days ago - iBio to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 23 days ago - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance - GlobeNewsWire
- 6 weeks ago - iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 6 weeks ago - iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025 - GlobeNewsWire
- 3 months ago - iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - iBio Announces Closing of $50 Million Public Offering - GlobeNewsWire
- 3 months ago - iBio Announces Pricing of $50 Million Public Offering - GlobeNewsWire